1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow ASP3082: new trials by email Literature Review of ASP3082 trials Research Report on ASP3082
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance ASP3082 - Metastatic/Locally Advanced Non-Small-Cell Lung Cancer, Metastatic/Locally Pancreatic Ductal Adenocarcinoma | Phase 2 | Recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 60 | 2026-03-25 | 2026-08-05 |
Gustave Roussy, Cancer Campus, Grand Paris (1)
France (1)
2025 (1)